RESUMO
PURPOSE: Magnetic resonance imaging (MRI) of the brain can provide valuable information about structural abnormalities in strabismus. The aim of this study was to evaluate the utility of MRI in this regard and to identify risk factors for abnormal MRI results in children with strabismus. METHODS: A retrospective analysis of children <18 years of age presenting with strabismus, who underwent brain MRI at Pusan National University Hospital (Busan, Korea) between January 2012 and March 2017, was performed. Clinical characteristics, MRI results, and ophthalmologic findings were reviewed. Findings were classified as normal or abnormal according to MRI results. Additionally, patients were divided according to age to compare characteristics of infantile and childhood strabismus. RESULTS: A total of 90 patients (47 [52.2%] male, 43 [47.8%] female; mean age, 2.19 ± 0.53 years) were enrolled. Of those, 64 (71.1%) presented with normal and 26 (28.9%) with abnormal MRI results. The age at presentation was lower and abnormal findings on fundus examination were more common in the abnormal MRI group (P = .002 and P = .008, respectively). Among the patients, 46 (51.1%) had infantile strabismus and 44 (48.9%) had childhood strabismus. Global developmental delays, speech delays, and MRI abnormalities were more common in patients with infantile than in those with childhood strabismus. Ptosis and headaches were more common in patients with childhood strabismus (P = .025, P = .025, respectively). CONCLUSION: Brain MRI was helpful for accurate diagnosis and treatment of strabismus in younger children, those with abnormal findings on fundus examination, and infants with developmental, especially speech, delays.
Assuntos
Encéfalo/diagnóstico por imagem , Imageamento por Ressonância Magnética , Estrabismo/diagnóstico por imagem , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Estudos RetrospectivosRESUMO
Anti-GQ1b antibody syndrome encompasses Miller Fisher syndrome and its related disorders. We retrospectively identified 11 pediatric patients (5.4-18â¯years old) with anti-GQ1b antibody syndrome. Diagnoses of patients included acute ophthalmoparesis (nâ¯=â¯6), classical Miller Fisher syndrome (nâ¯=â¯2), Miller Fisher syndrome/Guillain-Barré syndrome (nâ¯=â¯1), acute ataxic neuropathy (nâ¯=â¯1), and pharyngeal-cervical-brachial weakness (nâ¯=â¯1). Nine patients (81.8%) fully recovered. Maturational change in GQ1b antigen expression and the accessibility of anti-GQ1b antibodies might be the cause of the difference of clinical manifestations in children with anti-GQ1b antibody syndrome.
Assuntos
Autoanticorpos/sangue , Gangliosídeos/sangue , Síndrome de Miller Fisher/sangue , Síndrome de Miller Fisher/epidemiologia , Oftalmoplegia/sangue , Oftalmoplegia/epidemiologia , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Síndrome de Miller Fisher/diagnóstico por imagem , Oftalmoplegia/diagnóstico por imagem , República da Coreia/epidemiologia , Estudos Retrospectivos , SíndromeRESUMO
PURPOSE: Bell's palsy is characterized by sudden onset of unilateral facial weakness. The use of corticosteroids for childhood Bell's palsy is controversial. This study aimed to identify clinical characteristics, etiology, and laboratory findings in childhood Bell's palsy, and to evaluate the efficacy of corticosteroid treatment. METHODS: We conducted a retrospective analysis of children under 19 years of age treated for Bell's palsy between January 2009 and June 2017, and followed up for over 1 month. Clinical characteristics, neuroimaging data, laboratory findings, treatments, and outcomes were reviewed. Patients with Bell's palsy were divided into groups with (group 1) and without (group 2) corticosteroid treatment. Differences in onset age, sex, laterality, infection and vaccination history, degree of facial nerve palsy, and prognosis after treatment between the groups were analyzed. RESULTS: One hundred patients were included. Mean age at presentation was 7.4±5.62 years. A total of 73 patients (73%) received corticosteroids with or without intravenous antiviral agents, and 27 (27%) received only supportive treatment. There was no significant difference in the severity, laboratory findings, or neuroimaging findings between the groups. Significant improvement was observed in 68 (93.2%) and 26 patients (96.3%) in groups 1 and 2, respectively; this rate was not significantly different between the groups (P=0.48). CONCLUSION: Childhood Bell's palsy showed good prognosis with or without corticosteroid treatment; there was no difference in prognosis between treated and untreated groups. Steroid therapy in childhood Bell's palsy may not significantly improve outcomes.
RESUMO
BACKGROUND: Prevalence of anaphylaxis is increasing steadily, but there is scant information about anaphylaxis. OBJECTIVE: To identify the prevalence of anaphylaxis and evaluate the cause and features of anaphylaxis according to age. METHOD: The relevance of gender, age, history of allergic diseases, causes and clinical symptoms in the treatment and prognosis of anaphylaxis were retrospectively evaluated in patients diagnosed with anaphylaxis in Pusan National University Hospital from January 2009 to June 2014. RESULTS: The 161 patients included 30 children and 131 adults. The prevalence of anaphylaxis in both children and adults increased during the study period. The most common triggers were food in children, especially in those <5 years of age, and drugs in adults. All of the children with episodes of anaphylaxis presented with cutaneous symptoms and 90% had respiratory symptoms. For adults, cardiovascular symptoms were more common. CONCLUSIONS: The prevalence of anaphylaxis increased in both children and adults, with a higher rate in children. The causes and symptoms of anaphylaxis may differ depending on age. Clinicians should understand the characteristics of anaphylaxis by age.